These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9659795)

  • 1. The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c.
    Sorsa T; Pollesello P; Solaro RJ
    Mol Cell Biochem; 2004 Nov; 266(1-2):87-107. PubMed ID: 15646030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics.
    Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca++ sensitizers impair cardiac relaxation in failing human myocardium.
    Hajjar RJ; Schmidt U; Helm P; Gwathmey JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):247-54. PubMed ID: 8996203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Ca2+ sensitizers on contraction, [Ca2+]i transient and myofilament Ca2+ sensitivity in diabetic rat myocardium: potential usefulness as inotropic agents.
    Ishitani T; Hattori Y; Sakuraya F; Onozuka H; Makino T; Matsuda N; Gando S; Kemmotsu O
    J Pharmacol Exp Ther; 2001 Aug; 298(2):613-22. PubMed ID: 11454923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes.
    Sugawara H; Sakurai K; Atsumi H; Nakada S; Tomoike H; Endoh M
    J Card Fail; 2000 Dec; 6(4):338-49. PubMed ID: 11145759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium sensitizers in chronic heart failure: inotropic interventions-reservation to preservation.
    Teramura S; Yamakado T
    Cardiologia; 1998 Apr; 43(4):375-85. PubMed ID: 9659795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Will calcium sensitizers play a role in the treatment of heart failure?
    Nielsen-Kudsk JE; Aldershvile J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S77-84. PubMed ID: 8907135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Ca2+ signaling and Ca2+ sensitizers.
    Endoh M
    Circ J; 2008 Dec; 72(12):1915-25. PubMed ID: 18981594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of calcium sensitizer].
    Sakata Y
    Clin Calcium; 2013 Apr; 23(4):575-82. PubMed ID: 23545748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure?
    Erhardt LR
    Ital Heart J; 2003 May; 4 Suppl 2():27S-33S. PubMed ID: 14635367
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.